Bridgefront Capital’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,481
Closed -$288K 599
2025
Q3
$288K Buy
9,481
+501
+6% +$15.2K 0.08% 408
2025
Q2
$282K Buy
+8,980
New +$297K 0.07% 451
2022
Q2
Sell
-4,466
Closed -$306K 330
2022
Q1
$306K Buy
4,466
+1,355
+44% +$96.5K 0.38% 103
2021
Q4
$246K Buy
+3,111
New +$260K 0.24% 188
2021
Q3
Sell
-2,640
Closed -$208K 442
2021
Q2
$208K Buy
+2,640
New +$202K 0.08% 496

Other funds holding ENOV

Bridgefront Capital's ENOV Position: Q4 2025 in Review

Bridgefront Capital sold out of Enovis (ENOV) in Q4 2025, closing a stake of 9,481 shares — an estimated $288K sold.

Bridgefront Capital first reported a position in ENOV in Q2 2021 and held it in 5 quarters. The position peaked at $306K in Q1 2022. 254 funds tracked by Wall St. Rank hold ENOV as of Q4 2025.

  • Bridgefront Capital reported no remaining Enovis position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 9,481 Enovis shares in Q4 2025, an estimated $288K.
  • Bridgefront Capital first reported a position in Enovis in Q2 2021 and held it in 5 quarters.
  • Bridgefront Capital's Enovis position peaked at $306K in Q1 2022.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.